Medical Independence, Privacy, and Innovation Act of 2003

Medical Independence, Privacy, and Innovation Act of 2003 - Amends the Internal Revenue Code to eliminate language making the medical expense deduction only apply to the extent the relevant expenses exceed 7.5 percent of adjusted gross income. Permits the deduction in computing adjusted gross income.

Exempts medical checking accounts from being subjected to certain taxes. Subjects such accounts to taxes on unrelated business income of charitable organizations. Allows a deduction equal to the amount paid in cash to an individual's medical checking account (up to $1,000, or $2,000 in the case of a joint return) and a credit (of up to $1,000) for contributions made to such account.

Excludes from gross income any amount paid or distributed out of a medical checking account which is used exclusively to pay qualified medical expenses of any account holder.

Decreases the minimum annual deductibles under a high deductible health plan for purposes of Archer medical savings accounts.

Makes modifications to regulations regarding the privacy of individually identifiable health information.

Amends title II (Old Age, Survivors and Disability Insurance) of the Social Security Act to establish new rules restricting the use of Social Security account numbers to applicable Social Security Administration and tax related purposes.

Prohibits a Federal agency from conditioning receipt of any Federal grant or contract on the adoption, by a State or State agency or by a political subdivision of a State, of a uniform standard for individual identification.

Amends the definition of drug in the Federal Food, Drug, and Cosmetic Act to exclude articles intended for use in the mitigation or prevention of disease in man or other animals. (Current law includes such articles in the definition).

Amends the Act to direct the Secretary to promulgate regulations permitting pharmacists and wholesalers to import prescription drugs from foreign nations, with such regulations to require that each such drug complies with sections of the Act pertaining to new drugs, adulterated drugs and devices, and misbranded drugs and devices, and with other applicable requirements of this Act. (Current law directs the Secretary to promulgate regulations permitting pharmacists and wholesalers to import prescription drugs, except for specified controlled substances and biological products).